Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Response to: 'Criteria for CAPS, is it all in the name?' by Touitou and Sarrabay.

Kuemmerle-Deschner JB, Benseler SM.

Ann Rheum Dis. 2017 May;76(5):e10. doi: 10.1136/annrheumdis-2016-210726. Epub 2016 Nov 29. No abstract available.

PMID:
27899375
2.

Criteria for CAPS, is it all in the name?

Touitou I, Sarrabay G.

Ann Rheum Dis. 2017 May;76(5):e9. doi: 10.1136/annrheumdis-2016-210681. Epub 2016 Nov 16. No abstract available.

PMID:
27852576
3.

Response to: 'Why CAPS criteria are not diagnostic criteria?' by Landewé and van der Heijde.

Kuemmerle-Deschner JB, Benseler SM.

Ann Rheum Dis. 2017 Apr;76(4):e8. doi: 10.1136/annrheumdis-2016-210786. Epub 2016 Dec 16. No abstract available.

PMID:
27986656
4.

Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome.

Kuemmerle-Deschner JB, Hofer F, Endres T, Kortus-Goetze B, Blank N, Weißbarth-Riedel E, Schuetz C, Kallinich T, Krause K, Rietschel C, Horneff G, Benseler SM.

Rheumatology (Oxford). 2016 Apr;55(4):689-96. doi: 10.1093/rheumatology/kev416. Epub 2015 Dec 14.

PMID:
26667214
5.

Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.

Jaeger VK, Hoffman HM, van der Poll T, Tilson H, Seibert J, Speziale A, Junge G, Franke K, Vritzali E, Hawkins PN, Kuemmerle-Deschner J, Walker UA.

Rheumatology (Oxford). 2017 Sep 1;56(9):1484-1491. doi: 10.1093/rheumatology/kex185.

PMID:
28482054
6.

Analysis of cryopyrin-associated periodic syndromes (CAPS) in German children: epidemiological, clinical and genetic characteristics.

Lainka E, Neudorf U, Lohse P, Timmann C, Bielak M, Stojanov S, Huss K, von Kries R, Niehues T.

Klin Padiatr. 2010 Nov;222(6):356-61. doi: 10.1055/s-0030-1265181. Epub 2010 Nov 5.

PMID:
21058222
7.

Why CAPS criteria are not diagnostic criteria?

Landewé RB, van der Heijde DM.

Ann Rheum Dis. 2017 Apr;76(4):e7. doi: 10.1136/annrheumdis-2016-210656. Epub 2016 Oct 31. No abstract available.

PMID:
27799158
8.

Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS).

Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, Kone-Paut I, Goldbach-Mansky R, Lachmann H, Blank N, Hoffman HM, Weissbarth-Riedel E, Hugle B, Kallinich T, Gattorno M, Gul A, Ter Haar N, Oswald M, Dedeoglu F, Cantarini L, Benseler SM.

Ann Rheum Dis. 2017 Jun;76(6):942-947. doi: 10.1136/annrheumdis-2016-209686. Epub 2016 Oct 4. Review.

PMID:
27707729
9.

Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes.

Bozkurt Y, Demir A, Erman B, Gül A.

Comput Math Methods Med. 2015;2015:893507. doi: 10.1155/2015/893507. Epub 2015 May 28.

10.

Guidelines for the management and treatment of periodic fever syndromes: Cryopyrin-associated periodic syndromes (cryopyrinopathies - CAPS).

Terreri MT, Bernardo WM, Len CA, da Silva CA, de Magalhães CM, Sacchetti SB, Ferriani VP, Piotto DG, Cavalcanti Ade S, de Moraes AJ, Sztajnbok FR, de Oliveira SK, Campos LM, Bandeira M, Santos FP, Magalhães CS.

Rev Bras Reumatol Engl Ed. 2016 Jan-Feb;56(1):44-51. doi: 10.1016/j.rbre.2015.08.020. Epub 2015 Oct 20. English, Portuguese.

11.

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.

Kullenberg T, Löfqvist M, Leinonen M, Goldbach-Mansky R, Olivecrona H.

Rheumatology (Oxford). 2016 Aug;55(8):1499-506. doi: 10.1093/rheumatology/kew208. Epub 2016 May 3.

12.

Canakinumab for treatment of cryopyrin-associated periodic syndrome.

Feist E, Burmester GR.

Expert Opin Biol Ther. 2010 Nov;10(11):1631-6. doi: 10.1517/14712598.2010.530653. Review.

PMID:
20955115
13.

Anakinra for cryopyrin-associated periodic syndrome.

Koné-Paut I, Galeotti C.

Expert Rev Clin Immunol. 2014 Jan;10(1):7-18. doi: 10.1586/1744666X.2014.861325. Epub 2013 Nov 21. Review.

PMID:
24308832
14.

Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review.

Labrousse M, Kevorkian-Verguet C, Boursier G, Rowczenio D, Maurier F, Lazaro E, Aggarwal M, Lemelle I, Mura T, Belot A, Touitou I, Sarrabay G.

Crit Rev Clin Lab Sci. 2018 Sep;55(6):432-442. doi: 10.1080/10408363.2018.1488805. Epub 2018 Jul 23.

PMID:
30035647
15.

Cryopyrin-associated periodic syndrome.

Posch C, Kaulfersch W, Rappersberger K.

Pediatr Dermatol. 2014 Mar-Apr;31(2):228-31. doi: 10.1111/j.1525-1470.2012.01812.x. Epub 2012 Aug 14.

PMID:
22891689
16.

[Cryopyrin-associated periodic syndromes].

Quartier P, Rodrigues F, Georgin-Lavialle S.

Rev Med Interne. 2018 Apr;39(4):287-296. doi: 10.1016/j.revmed.2017.09.002. Epub 2017 Oct 27. French.

PMID:
29111302
17.

Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan.

Yokota S, Nishikomori R, Takada H, Kikuchi M, Nozawa T, Kanetaka T, Kizawa T, Miyamae T, Mori M, Heike T, Hara T, Imagawa T.

Mod Rheumatol. 2013 May;23(3):425-9. doi: 10.1007/s10165-012-0769-8. Epub 2012 Oct 20. Review.

PMID:
23085882
18.

Cryopyrin-associated periodic syndrome in Australian children and adults: Epidemiological, clinical and treatment characteristics.

Mehr S, Allen R, Boros C, Adib N, Kakakios A, Turner PJ, Rogers M, Zurynski Y, Singh-Grewal D.

J Paediatr Child Health. 2016 Sep;52(9):889-95. doi: 10.1111/jpc.13270.

19.

[An approach to the patients with cryopyrin-associated periodic syndrome (CAPS) : a new biologic response modifier, canakinumab].

Yokota S, Kikuchi M, Nozawa T, Kizawa T, Kanetaka T, Miyamae T, Mori MA, Nishikomori R, Takata H, Heike T, Hara T, Imagawa T.

Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(1):23-9. Review. Japanese.

20.

Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion.

Tassi S, Carta S, Delfino L, Caorsi R, Martini A, Gattorno M, Rubartelli A.

Proc Natl Acad Sci U S A. 2010 May 25;107(21):9789-94. doi: 10.1073/pnas.1000779107. Epub 2010 May 5.

Supplemental Content

Support Center